Maximilian Molitor
Overview
Explore the profile of Maximilian Molitor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hyprath M, Molitor M, Schweighofer I, Marschalek R, Steinhilber D
Front Pharmacol
. 2025 Jan;
15:1520507.
PMID: 39877387
5-Lipoxygenase (5-LO), encoded by the gene , is implicated in several pathologies. As key enzyme in leukotriene biosynthesis, 5-LO plays a central role in inflammatory diseases, but the 5-LO pathway...
2.
Molitor M, Menge A, Mandel S, George S, Muller S, Knapp S, et al.
Pflugers Arch
. 2024 Sep;
476(12):1913-1928.
PMID: 39347835
Human 5-lipoxygenase (5-LO) is the key enzyme in the biosynthesis of leukotrienes, mediators of the innate immune system that also play an important role in inflammatory diseases and cancer. In...
3.
Sharma R, Singh S, Whiting Z, Molitor M, Vernall A, Grimsey N
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047385
Cannabinoid Receptor 2 (CB2) is a promising target for treating inflammatory diseases. We designed derivatives of 3-carbamoyl-2-pyridone and 1,8-naphthyridin-2(1H)-one-3-carboxamide CB2-selective agonists with reduced lipophilicity. The new compounds were measured for...